Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy

Retina

Volumn 29, Issue 10, 2009, Pages 1522-1526

  Sakurada, Yoichi ^a   Kubota, Takeo ^a   Imasawa, Mitsuhiro ^a   Tsumura, Toyoaki ^a   Mabuchi, Fumihiko ^a   Tanabe, Naohiko ^a   Iijima, Hiroyuki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LESIONS AND DEFECTS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYPOIDAL CHOROIDAL VASCULOPATHY; VISUAL ACUITY; CHOROID; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PERIPHERAL VASCULAR DISEASE; POLYMERASE CHAIN REACTION; RETINA FOVEA; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULARIZATION;

ARMS2 PROTEIN, HUMAN; COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN; PROTEIN;

AGED; CHOROID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; GENOTYPE; HUMANS; INDOCYANINE GREEN; MALE; PERIPHERAL VASCULAR DISEASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 73349137354     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181af0d72     Document Type: Article

References (31)

1. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10:1-8.
2. Moorthy RS, Lyon AT, Rabb MF, Spaide RF, Yannuzzi LA, Jampol LM. Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology 1998;105:1380-1385.
3. Iida T. Diagnostic criteria for polypoidal choroidal vasculopathy and their clinical significance [in Japanese]. Nippon Ganka Gakkai Zasshi 2005;109:383-384.
4. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995;15:100-110.
5. Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997; 115:478-485.
6. Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007;144:15-22.
7. Sho K, Takahashi K, Yamada H, et al.. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003;121:1392-1396.
8. Ogino T, Takeda M, Imaizumi H, Okushiba U. Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year. Jpn J Ophthalmol 2007;51:210-215.
9. Gomi F, Ohji M, Sayanagi K, et al.. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2008;115:141-146.
10. Akaza E, Yuzawa M, Matsumoto Y, Kashiwakura S, Fujita K, Mori R. Role of photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2007;51:270-277.
11. Spaide RF, Donsoff I, Lam DL, et al.. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina 2002;22:529-535.
12. Chan WM, Lam DS, Lai TY, et al.. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology 2004;111:1576-1584.
13. Silva RM, Figueira J, Cachulo ML, Duarte L, Faria De Abreu JR, Cunha-Vaz JG. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2005;243:973-979.
14. Otani A, Sasahara M, Yodoi Y, et al.. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2007;144:7-14.
15. Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina 2007;27:825-831.
16. Dewan A, Liu M, Hartman S, et al.. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006;314:989-992.
17. Rivera A, Fisher SA, Fritsche LG, et al.. Hypothetical LOC387715 is a second major susceptibility gene for agerelated macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14:3227-3236.
18. Yang Z, Camp NJ, Sun H, et al.. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006;314:992-993.
19. Lin JM, Wan L, Tsai YY, et al.. HTRA1 polymorphism in dry and wet age-related macular degeneration. Retina 2008;28: 309-313.
20. Tanimoto S, Tamura H, Ue T, et al.. A polymorphism of LOC387715 gene is associated with age-related macular degeneration in the Japanese population. Neurosci Lett 2007; 414:71-74.
21. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 2007;144:608-612.
22. Shuler RK, Jr., Schmidt S, Gallins P, et al.. Phenotype analysis of patients with the risk variant LOC387715 (A69S) in agerelated macular degeneration. Am J Ophthalmol 2008;145: 303-307.
23. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007;297:1793-1800.
24. Brantley MA, Jr., Fang AM, King JM, Tewari A, Kymes SM, Shiels A. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology 2007;114:2168-2173.
25. Sakurada Y, Kubota T, Mabuchi F, Imasawa M, Tanabe N, Iijima H. Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy. Am J Ophthalmol 2008;145:1058-1062.
26. Gomi F, Sawa M, Mitarai K, Tsujikawa M, Tano Y. Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2007;245:1421-1427.
27. Wegscheider BJ, Weger M, Renner W, et al.. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 2007;114:738-742. (Pubitemid 46483679)
28. Brantley MA, Jr., Edelstein SL, King JM, Apte RS, Kymes SM, Shiels A. Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration. Am J Ophthalmol 2007;144:404-408.
29. Blinder KJ, Bradley S, Bressler NM, et al.. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. Am J Ophthalmol 2003;136:407-418.
30. Hirami Y, Tsujikawa A, Otani A, et al.. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 2007;27:335-341. (Pubitemid 46398898)
31. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to agerelated macular degeneration. Am J Ophthalmol 2003;136: 1049-1061.